Waldencast plc Announces Intention to Voluntarily Delist from Nasdaq and Deregister its Securities under the Exchange Act

Waldencast plc announced its decision to voluntarily delist from Nasdaq and deregister its securities under the Exchange Act, with the last trading day expected on October 2, 2026. Following the sale of Obagi Medical, the company will become a single-brand entity focused on Milk Makeup and plans to rename itself Milk Makeup plc. The delisting is driven by disproportionate compliance costs, limited trading volume, and the company's reduced need for public equity market access after debt paydown.